Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology

Glioblastoma multiforme

Alabama

Birmingham : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Colorado

Aurora : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Florida

Tampa : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Illinois

Evanston : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Massachusetts

Boston : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Michigan

Detroit : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

New Jersey

Morristown : Atlantic Health System

Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer

New York

Manhasset : Biomedical Research Alliance of New York

Glioblastoma (Brain Tumor) and Unmethylated MGMT Gene - Adults

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

North Carolina

Charlottesville : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Durham : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Ohio

Cincinnati : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Tennessee

Nashville : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Australia

Nedlands : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

North Adelaide : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Parkville : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Randwick : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

St Leonards : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Woolloongabba : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Belgium

Bruxelles : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Bruxelles : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Edegem : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Gent : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Liège : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Roeselare : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Canada

Calgary, AB : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Edmonton, AB : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Hamilton, ON : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Kingston, ON : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

London, ON : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Montreal, QC : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Ottawa, ON : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Quebec City, QC : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Saskatoon, SK : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Toronto, ON : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Vancouver, BC : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Winnipeg, MB : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Denmark

Aalborg : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Copenhagen : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Odense : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

France

Bobigny : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Bordeaux : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Bron : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Clermont-Ferrand : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Clichy : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Dijon : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Marseille : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Montpellier : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Nancy : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Nice : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Paris : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Paris : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Saint Herblain : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Villejuif : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Villejuif : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Germany

Berlin : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bochum : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bonn : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Chemnitz : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Dresden : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Dresden : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Dülmen : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Düsseldorf : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Erfurt : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Frankfurt Am Main : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Freiburg : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Giessen : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Göttingen : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Hamburg : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Heidelberg : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Kiel : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Leipzig : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Mainz : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Mannheim : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Marburg : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

München : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

München : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Münster : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Oldenburg : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Regensburg : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Tübingen : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Velen : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Greece

Athens : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Heracleion : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Larissa : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Thessaloniki : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Hong Kong

Hong Kong : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Hungary

Budapest : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Miskolc : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Pecs : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Szeged : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Israel

Haifa : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Jerusalem : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Petach Tikva : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Tel Hashomer : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Italy

Bologna : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Forli-Cesena : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Milano : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Padova : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Roma : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Terni : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Torino : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Torino : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Treviso : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Japan

Hiroshima : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Ibaraki : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Kumamoto : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Osaka : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Saitama : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Tokyo : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Korea, Republic of

Busan : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Daegu : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Goyang-Si : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Hwasun : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Seongnam-Si : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Seoul : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Netherlands

Amsterdam : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Den Haag : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Eindhoven : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Nijmegen : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Utrecht : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

New Zealand

Auckland : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Christchurch : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Hamilton : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Poland

Bialystok : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Portugal

Coimbra : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Lisboa : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Porto : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Romania

Bucharest : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Cluj-Napoca : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Targu Mures : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Russian Federation

Moscow : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

St. Petersburg : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Spain

Barcelona : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Hospitalet de Llobregat : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Madrid : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Malaga : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Valencia : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Sweden

Göteborg : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Lund : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Umea : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Uppsala : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Switzerland

Bern : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Genève 14 : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

United Kingdom

Birmingham : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Bristol : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Glasgow : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

London : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Manchester : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Newcastle upon Tyne : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Nottingham : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Romford : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Sheffield : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Sutton : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

Wirral : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

USA

Los Angeles : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma